NCT00930332 2024-02-12
Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer Pain
Canadian Cancer Trials Group
Phase 1 Terminated
Clinical Trials
4 trialsNCT05251376 2023-01-19
Study of LYN-014 in Individuals With Opioid Use Disorder Who Are Stable on Methadone Therapy
Lyndra Inc.
Phase 1 Withdrawn
NCT02531906 2022-07-25
Gabapentin, Methadone Hydrochloride, and Oxycodone Hydrochloride in Improving Quality of Life in Patients With Stage II-IV Head and Neck Cancer During Chemoradiation
Roswell Park Cancer Institute
Phase 1 Completed
NCT00125294 2017-09-25
Sublingual Methadone for the Management of Cancer Breakthrough Pain
AHS Cancer Control Alberta
Phase 1 Completed